242 related articles for article (PubMed ID: 23762870)
1. Systemic delivery of tyrosine-mutant AAV vectors results in robust transduction of neurons in adult mice.
Iida A; Takino N; Miyauchi H; Shimazaki K; Muramatsu S
Biomed Res Int; 2013; 2013():974819. PubMed ID: 23762870
[TBL] [Abstract][Full Text] [Related]
2. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
3. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
[TBL] [Abstract][Full Text] [Related]
4. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies.
Bailey RM; Rozenberg A; Gray SJ
Brain Res; 2020 Jul; 1739():146832. PubMed ID: 32289279
[TBL] [Abstract][Full Text] [Related]
5. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
[TBL] [Abstract][Full Text] [Related]
6. Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats.
Bucher T; Dubreil L; Colle MA; Maquigneau M; Deniaud J; Ledevin M; Moullier P; Joussemet B
Gene Ther; 2014 May; 21(5):522-8. PubMed ID: 24572783
[TBL] [Abstract][Full Text] [Related]
7. Selective transgene expression in cerebellar Purkinje cells and granule cells using adeno-associated viruses together with specific promoters.
Kim Y; Kim T; Rhee JK; Lee D; Tanaka-Yamamoto K; Yamamoto Y
Brain Res; 2015 Sep; 1620():1-16. PubMed ID: 25988836
[TBL] [Abstract][Full Text] [Related]
8. Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord.
Dirren E; Towne CL; Setola V; Redmond DE; Schneider BL; Aebischer P
Hum Gene Ther; 2014 Feb; 25(2):109-20. PubMed ID: 24191919
[TBL] [Abstract][Full Text] [Related]
9. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
[TBL] [Abstract][Full Text] [Related]
10. The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration.
Beharry A; Gong Y; Kim JC; Hanlon KS; Nammour J; Hieber K; Eichler F; Cheng M; Stemmer-Rachamimov A; Stankovic KM; Welling DB; Ng C; Maguire CA
Hum Gene Ther; 2022 Jan; 33(1-2):61-75. PubMed ID: 34128391
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine Mutation in AAV9 Capsid Improves Gene Transfer to the Mouse Lung.
Martini SV; Silva AL; Ferreira D; Rabelo R; Ornellas FM; Gomes K; Rocco PR; Petrs-Silva H; Morales MM
Cell Physiol Biochem; 2016; 39(2):544-53. PubMed ID: 27384068
[TBL] [Abstract][Full Text] [Related]
12. Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates.
Gray SJ; Matagne V; Bachaboina L; Yadav S; Ojeda SR; Samulski RJ
Mol Ther; 2011 Jun; 19(6):1058-69. PubMed ID: 21487395
[TBL] [Abstract][Full Text] [Related]
13. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.
Foust KD; Nurre E; Montgomery CL; Hernandez A; Chan CM; Kaspar BK
Nat Biotechnol; 2009 Jan; 27(1):59-65. PubMed ID: 19098898
[TBL] [Abstract][Full Text] [Related]
14. AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice.
Besse A; Astord S; Marais T; Roda M; Giroux B; Lejeune FX; Relaix F; Smeriglio P; Barkats M; Biferi MG
Mol Ther; 2020 Aug; 28(8):1887-1901. PubMed ID: 32470325
[TBL] [Abstract][Full Text] [Related]
15. Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery.
Snyder BR; Gray SJ; Quach ET; Huang JW; Leung CH; Samulski RJ; Boulis NM; Federici T
Hum Gene Ther; 2011 Sep; 22(9):1129-35. PubMed ID: 21443428
[TBL] [Abstract][Full Text] [Related]
16. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates.
Gray SJ; Nagabhushan Kalburgi S; McCown TJ; Jude Samulski R
Gene Ther; 2013 Apr; 20(4):450-9. PubMed ID: 23303281
[TBL] [Abstract][Full Text] [Related]
17. Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.
Bey K; Ciron C; Dubreil L; Deniaud J; Ledevin M; Cristini J; Blouin V; Aubourg P; Colle MA
Gene Ther; 2017 May; 24(5):325-332. PubMed ID: 28425480
[TBL] [Abstract][Full Text] [Related]
18. Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs.
Federici T; Taub JS; Baum GR; Gray SJ; Grieger JC; Matthews KA; Handy CR; Passini MA; Samulski RJ; Boulis NM
Gene Ther; 2012 Aug; 19(8):852-9. PubMed ID: 21918551
[TBL] [Abstract][Full Text] [Related]
19. Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders.
Bevan AK; Duque S; Foust KD; Morales PR; Braun L; Schmelzer L; Chan CM; McCrate M; Chicoine LG; Coley BD; Porensky PN; Kolb SJ; Mendell JR; Burghes AH; Kaspar BK
Mol Ther; 2011 Nov; 19(11):1971-80. PubMed ID: 21811247
[TBL] [Abstract][Full Text] [Related]
20. Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain.
Zhang X; Chai Z; Lee Dobbins A; Itano MS; Askew C; Miao Z; Niu H; Samulski RJ; Li C
Biomaterials; 2022 Feb; 281():121340. PubMed ID: 34998171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
